Home / BTG3 Knockout Cell Lines

BTG3 Knockout Cell Lines

Gene: BTG3

Official Full Name: BTG anti-proliferation factor 3provided by HGNC

Gene Summary: The protein encoded by this gene is a member of the BTG/Tob family. This family has structurally related proteins that appear to have antiproliferative properties. This encoded protein might play a role in neurogenesis in the central nervous system. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO05588 BTG3 Knockout cell line (HeLa) Human BTG3 1:3~1:6 Negative Online Inquiry
KO05589 BTG3 Knockout cell line (HCT 116) Human BTG3 1:2~1:4 Negative Online Inquiry
KO05590 BTG3 Knockout cell line (HEK293) Human BTG3 1:3~1:6 Negative Online Inquiry
KO05591 BTG3 Knockout cell line (A549) Human BTG3 1:3~1:4 Negative Online Inquiry

Background

BTG3 Gene Knockout Cell Lines are highly specialized cell lines engineered to lack the BTG3 gene, which encodes a protein involved in various cellular processes, including cell cycle regulation, differentiation, and apoptosis. These knockout cell lines serve as invaluable tools for elucidating the specific roles of BTG3 in pathophysiological conditions and for assessing gene function through loss-of-function studies.

The primary function of these cell lines lies in their capacity to uncover the molecular mechanisms and signaling pathways influenced by BTG3. By eliminating this gene, researchers can investigate its impact on cellular behaviors such as proliferation, survival, and response to stressors, providing insight into the underlying mechanisms associated with diseases, including cancer and metabolic disorders.

The scientific importance of BTG3 Gene Knockout Cell Lines extends to both research and clinical applications. In basic research, these cell lines can be used to explore gene function, screen potential therapeutic compounds, and develop models for disease mechanisms. In a clinical context, understanding BTG3's role opens avenues for targeted therapies and personalized medicine, particularly where the regulatory functions of this gene impact treatment response or disease progression.

One of the key advantages of our BTG3 Gene Knockout Cell Lines is their high specificity and reproducibility, thanks to advanced CRISPR/Cas9 gene-editing technologies employed in their development. Compared to other gene knockout models, our cell lines exhibit enhanced fidelity, allowing for more reliable experimental outcomes. Furthermore, they are readily available in various cellular backgrounds, accommodating a wide range of research applications.

For researchers and clinicians seeking to unlock the intricacies of gene function and its implications in disease, our BTG3 Gene Knockout Cell Lines represent a unique and valuable resource. Their precision and reliability empower users to generate meaningful data that can directly inform therapeutic strategies.

Our company prides itself on its commitment to advancing scientific discovery through high-quality, rigorously validated biological products. With expertise in genetic engineering and a focus on customer support, we strive to provide researchers with the tools they need to accelerate their work and achieve transformational outcomes.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.